Healthtech Investors & VC Firms in Asia-Pacific

838 firms in this list, with a median first check of $600K. 163 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
QC QC·VENTURES FSAGMUTB7 people	88🔒	Vienna	AT	Seed–Late Stage	$216K – $4.3M	+ Add to CRM
AR Artiman Ventures ASBWRRTD9 people	88🔒	Palo Alto	US	Seed–Late Stage	$2M – $6M	+ Add to CRM
OQ Oquirrh Ventures JSJYJKRH6 people	88🔒	Salt Lake City	US	Growth–Late Stage	$10M – $50M	+ Add to CRM
NE Newtown Partners LTLCVLAM4 people	88🔒	Cape Town	ZA	Seed–Growth	—	+ Add to CRM
ST Storytime Capital RKLENGJF5 people · Leads rounds	88🔒	Toronto	CA	Pre-Seed–Series A	—	+ Add to CRM
AC Acumen JNCSCLST7 people	88🔒	New York	US	Seed–Growth	—	+ Add to CRM
PR Princeville Capital JKJRTMUC15 people	88🔒	San Francisco	US	Series A–Late Stage	—	+ Add to CRM
RO Romulus Capital KKNCBMTS4 people · Follows rounds	88🔒	Boston	US	Seed–Late Stage	$250K – $10M	+ Add to CRM
HB HBM Partners FDCLDDDU5 people	88🔒	Zug	CH	Pre-Seed–Late Stage	$5M – $50M	+ Add to CRM
TV TVM Capital DHHBSFKM6 people · Leads rounds	88🔒	Munich	DE	Seed–Late Stage	$1.1M – $16.2M	+ Add to CRM
ON Ono Venture Investment, Inc. SMDNHTKT6 people	88🔒	South San Francisco	US	Seed–Series B	—	+ Add to CRM
MA Magnivia Ventures PSSSAAJM7 people	88🔒	New Jersey	US	Pre-Seed–Series B	$250K – $750K	+ Add to CRM
IN Inflexion DW1 person · Leads rounds	88🔒	London	GB	Series B–Growth	$1.1B	+ Add to CRM
OP OpenAI Startup Fund SABLIH3 people · Leads rounds	88🔒	San Francisco	US	Seed–Series A	$1M	+ Add to CRM
FU Future Positive Capital SHPR2 people · Follows rounds	88🔒	—	FR	Pre-Seed–Series A	—	+ Add to CRM
PR Prana Tech Ventures HJMTPPVN4 people · Leads rounds	88🔒	New York	US	Pre-Seed–Seed	—	+ Add to CRM
BL BlueOcean Ventures EDFSSHTZ6 people · Leads rounds	88🔒	Geneva	CH	Pre-Seed–Series A	$270K – $1.4M	+ Add to CRM
CE Century Oak Ventures	88🔒	Dubai	AE	Pre-Seed–Series A	$250K – $2.6M	+ Add to CRM
RO Rocket Capital ADJQCGMD9 people	88🔒	Amsterdam	NL	Series B–Late Stage	—	+ Add to CRM
DO DoubleRock NDSR2 people	88🔒	San Francisco	US	Seed–Series A	$2M – $15M	+ Add to CRM
AG Agate Medical Investments LP	88🔒	Tel-Aviv	IL	Growth–Late Stage	—	+ Add to CRM
LE Legendary Ventures, Llc. JDMLAKZD9 people	88🔒	New York City	US	Seed–Late Stage	—	+ Add to CRM
DE DEFTA Partners KWGHMIST5 people	88🔒	San Francisco	US	Seed–Series A	—	+ Add to CRM
RO Rosetta Capital Ltd. JHKMMFDL8 people	88🔒	Oxford	GB	Series A–Late Stage	—	+ Add to CRM

QC·VENTURES

ViennaSeed–Late Stage$216K – $4.3M

FSAGMUTB7 people

Artiman Ventures

Palo AltoSeed–Late Stage$2M – $6M

ASBWRRTD9 people

Oquirrh Ventures

Salt Lake CityGrowth–Late Stage$10M – $50M

JSJYJKRH6 people

Newtown Partners

Cape TownSeed–Growth

LTLCVLAM4 people

Storytime Capital

TorontoPre-Seed–Series A

RKLENGJF5 people

Acumen

New YorkSeed–Growth

JNCSCLST7 people

Princeville Capital

San FranciscoSeries A–Late Stage

JKJRTMUC15 people

Romulus Capital

BostonSeed–Late Stage$250K – $10M

KKNCBMTS4 people

HBM Partners

ZugPre-Seed–Late Stage$5M – $50M

FDCLDDDU5 people

TVM Capital

MunichSeed–Late Stage$1.1M – $16.2M

DHHBSFKM6 people

Ono Venture Investment, Inc.

South San FranciscoSeed–Series B

SMDNHTKT6 people

Magnivia Ventures

New JerseyPre-Seed–Series B$250K – $750K

PSSSAAJM7 people

Inflexion

LondonSeries B–Growth$1.1B

DW1 person

OpenAI Startup Fund

San FranciscoSeed–Series A$1M

SABLIH3 people

Future Positive Capital

Pre-Seed–Series A

SHPR2 people

Prana Tech Ventures

New YorkPre-Seed–Seed

HJMTPPVN4 people

BlueOcean Ventures

GenevaPre-Seed–Series A$270K – $1.4M

EDFSSHTZ6 people

Century Oak Ventures

DubaiPre-Seed–Series A$250K – $2.6M

Rocket Capital

AmsterdamSeries B–Late Stage

ADJQCGMD9 people

DoubleRock

San FranciscoSeed–Series A$2M – $15M

NDSR2 people

Agate Medical Investments LP

Tel-AvivGrowth–Late Stage

Legendary Ventures, Llc.

New York CitySeed–Late Stage

JDMLAKZD9 people

DEFTA Partners

San FranciscoSeed–Series A

KWGHMIST5 people

Rosetta Capital Ltd.

OxfordSeries A–Late Stage

JHKMMFDL8 people

Data sourced from public filings and firms' own websites — see our methodology.